UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Psychotic disorders in COVID-19: mechanisms of development, clinical and treatment feature

Type of Article

In the Section

Index UDK:

Abstract

The purpose of this review was to study the mechanisms of development, clinical features and treatment of psychotic disorders during the disease caused by the SARS-CoV-2 virus. In the first part of the review, especial attention was paid to the available literature data on the mechanisms of development of mental disorders in COVID-19. Among the main pathogenetic mechanisms of the onset of psychotic disorders in coronavirus infections, there are direct effects of a viral infection (including a brain infection), cerebrovascular diseases, hypoxia, an immunological response, the consequences of medical interventions, social isolation, the psychological impact of a severe and potentially fatal illness, fears of infecting another’s and stigmatization. The second part of the publication is devoted to a review of clinical studies and syndromokinesis in infectious and coronavirus psychoses. Particular attention is paid to delirious syndrome, including pharmacogenic delirium and antibiotic-associated encephalopathy.

The article describes the features of therapy for psychotic disorders in COVID-19, taking into account drug-drug interactions and the effect on the cardiovascular and respiratory systems.

The analyzed literature allows us to make a reasonable conclusion that the management of coronavirus psychoses should be aimed at treating the underlying disease while eliminating psychotic symptoms with antipsychotics while ensuring maximum safety of psychopharmacotherapy.

Pages

References

  1. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to  the COVID-19 pandemic  / Rogers, J. P., Chesney, E., Oliver, D. [et al.] // The Lancet. Psychiatry. 2020. Vol. 7, Issue 7. P. 611—627. DOI: https://doi.org/10.1016/S2215-0366(20)30203-0.
  2. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA / Taquet, M., Luciano, S., Geddes, J. R. [et al.] // The Lancet Psychiatry. 2020. DOI: https://doi.org/10.1016/S2215-0366(20)30462-4.
  3. Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: a nationwide case-control study / W. Ji, K. Huh, M. Kang [et al.] // Journal of Korean Medical Science. 2020. Vol. 35, No.  P.  e237. DOI: https://doi.org/10.3346/jkms.2020.35.e237.
  4. Pre-pandemic psychiatric disorders and risk of COVID-19: a UK biobank cohort analysis / H. Yang, W. Chen, Y. Hu [et al.] // The Lancet Healthy Longevity. 2020. Vol. 1, No. 2. P. e69—e79. DOI: https://doi.org/10.1016/S2666-7568(20)30013-1.
  5. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms / E. G. Severance, F. B. Dickerson, R. P. Viscidi [et al.] // Schizophrenia Bulletin. 2011. Vol. 37, No. 1. P. 101—107. DOI: https://doi.org/10.1093/schbul/sbp052.
  6. COVID-19-induced psychosis and suicidal behavior: case report / M. Chacko, A. Job, F. Caston [et al.] // SN Comprehensive Clinical Medicine. 2020. DOI: https://doi.org/10.1007/s42399-020-00530-7.
  7. The potential impact of COVID-19 on psychosis: a rapid review of contemporary epidemic and pandemic research / E. Brown, R. Gray, S. Lo Monaco [et al.] // Schizophrenia Research. 2020. Vol.  P.  79—87. DOI: https://doi.org/10.1016/j.schres.2020.05.005.
  8. Compton, M. T., Shim, R. S. The social determinants of mental health // Focus. 2015. Vol. 13, Issue 4. P. 419—425. DOI: https://doi.org/10.1176/appi.focus.20150017.
  9. Anglin, D. M., Galea, S., Bachman, P. Going upstream to advance psychosis prevention and improve public health // JAMA Psychiatry. 2020. Vol. 77, No. 7. P. 665—666. DOI: https://doi.org/10.1001/jamapsychiatry.2020.0142.
  10. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? / S.   Ferrando, L.  Klepacz, S.  Lynch [et al.] // Psychosomatics. 2020. Vol. 61, No. 5. P. 551—555. DOI: https://doi.org/10.1016/j.psym.2020.05.012.
  11. Troyer, E. A., Kohn, J. N., Hong, S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms // Brain, Behavior, and Immunity. 2020. Vol. P.  34—39. DOI: https://doi.org/10.1016/j.bbi.2020.04.027.
  12. Command suicidal hallucination as initial presentation of coronavirus disease 2019 (COVID-19): a case report / J.  Mirza, A.  Ganguly, A.  Ostrovskaya [et  ]  // Psychosomatics. 2020. Vol. 61, No. 5. P. 561—564. DOI: https://doi.org/10.1016/j.psym.2020.05.022.
  13. Nervous system involvement after infection with COVID-19 and other coronaviruses / Y. Wu, X. Xu, Z. Chen [et al.] // Brain, Behavior, and Immunity. 2020. Vol. P. 18—22. DOI: https://doi.org/10.1016/j.bbi.2020.03.031.
  14. Huarcaya-Victoria, J., Meneses-Saco, A., Luna-Cuadros, M. A. Psychotic symptoms in COVID-19 infection: a case series from Lima, Peru // Psychiatry Research. 2020. Vol. 293. P. 113378. DOI: https://doi.org/10.1016/j.psychres.2020.113378.
  15. COVID-19-associated brief psychotic disorder / C. M. Smith, J. R. Komisar, A. Mourad [et al.] // BMJ Case Reports. 2020. Vol. 13, No. 8. P. e236940. DOI: https://doi.org/10.1136/bcr-2020-236940.
  16. Yurieva, L. N., Shusterman, T. I. The COVID-19 pandemic: risks for psychological well-being and mental health // Ukrainian Journal of Psychoneurology. 2020. Vol. 28, Issue 2 (103). C. 5-10. DOI: https://doi.org/10.36927/2079-0325-V28-is2-2020-1.
  17. Treatment and prevention of COVID-19. Mental health care in a pandemic: edited by O. Abaturov, S. Kramarev, L. Yurieva. Lviv : Marchenko T. V., 2020. 252 c.
  18. Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement / S. R. Beach, N. C. Praschan, C. Hogan [et al.] // General Hospital Psychiatry. 2020. Vol. 65. P. 47—53. DOI: https://doi.org/10.1016/j.genhosppsych.2020.05.008.
  19. Antibiotic-associated encephalopathy / S. Bhattacharyya, R. R. Darby, P. Raibagkar [et al.] // Neurology. 2016. Vol. 86, No. 10. P. 963—971. DOI: https://doi.org/10.1212/WNL.0000000000002455.
  20. Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry, Third Edition. Edited by: Levenson J. L. American Psychiatric Association Publishing, 2018. 1594 p. DOI: https://doi.org/10.1176/appi.books.9781615371990.
  21. Central nervous system disorders after starting antiretroviral therapy in South Africa / V. Asselman, F. Thienemann, D. J. Pepper [et al.] // AIDS. 2010. Vol. 24, No. 18. P. 2871—2876. DOI: https://doi.org/10.1097/QAD.0b013e328340fe76.
  22. The HIV antiretroviral drug efavirenz has LSD-like properties / M.   Gatch, A.  Kozlenkov, R.-Q.  Huang [et  al.]  // Neuropsychopharmacology. 2013. Vol. 38, No. 12. P. 2373—2384. DOI: https://doi.org/10.1038/npp.2013.135.
  23. Psychiatry of Pandemics: A Mental Health Response to Infection Outbreak / Editor: D.  Huremović. Cham  : Springer International Publishing, 2019. 185 p. URL: https://www.springer.com/gp/book/9783030153458.
  24. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases / S.  -W.  Cheng, J.  S.-K.  Tsang, K.-H.  Ku [et al.] // The British Journal of Psychiatry. 2004. Vol. 184, No. 4. P. 359—360. DOI: https://doi.org/10.1192/bjp.184.4.359.
  25. Reactive psychoses in the context of the COVID-19 pandemic: clinical perspectives from a case series / M. J. ValdésFlorido, Á. López-Díaz, F.    Palermo-Zeballos [et  al.]  // Revista De  Psiquiatria Y Salud Mental. 2020. Vol.  13, No.  2. P.  90—94. DOI: https://doi.org/10.1016/j.rpsm.2020.04.009.
  26. An investigation of mental health status of children and adolescents in china during the outbreak of  COVID-19  / L. Duan, X. Shao, Y. Wang [et al.] // Journal of Affective Disorders. 2020. Vol.  P.  112—118. DOI: https://doi.org/10.1016/j.jad.2020.06.029.
  27. The SARS-CoV-2 and mental health: from biological mechanisms to social consequences / D. Szcześniak, A. Gładka, B. Misiak [et ]  // Progress in Neuro-Psychopharmacology &  Biological Psychiatry. 2021. Vol.  104. P.  110046. DOI: https://doi.org/10.1016/j.pnpbp.2020.110046.
  28. Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode / J. A. Mawhinney, C. Wilcock, H. Haboubi, and S. Roshanzamir // BMJ Case Reports CP. 2020. Vol. 13, No. 6. P. e236123. DOI: https://doi.org/10.1136/bcr-2020-236123.
  29. Organic mental disorders: diagnosis, rehabilitation and prevention / edited by L. M. Yurieva. Dnipro: New Ideology, 2019. 124 c.
  30. Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients / P. Li, Y.  Wang, M. P. Peppelenbosch [et al.] // International Journal of Infectious Diseases. 2020. DOI: https://doi.org/10.1016/j.ijid.2020.11.127.
  31. González-Rodríguez A., Labad J. Mental health in times of covid: thoughts after the state of alarm  // Medicina Clinica (English Ed.). 2020. Vol. 155, No. 9. P. 392—394. DOI: https://doi.org/10.1016/j.medcle.2020.07.007.
  32. Recommendations of the Association of Neurologists, Psychiatrists and Narcologists of Ukraine on the provision of psychiatric care during the COVID-19 epidemic / Voloshyn, P.V., Maruta, N.O., Linsky, I.V. [et al. 9 с. URL: https://inpn.org.ua/news/34.